Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FICB vs Fentanyl for Positioning in Femur Fracture
NCT02983344Completed
- Sponsor
- Hospital Kuala Lumpur
- Start
- Oct 2015
- Primary completion
- Dec 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in femoral fracture (2 arms), sponsored by Hospital Kuala Lumpur. Primary endpoint: Pain score during positioning. Started Oct 2015; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
femoral fracture
Beyond the preview
Go deeper on NCT02983344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983344.